Evidence map›Paper›PMID 21806470›Full record

ArticleJournal of neurotrauma2012

Activation of the nuclear factor E2-related factor 2/antioxidant response element pathway is neuroprotective after spinal cord injury.

Xiaoliang Wang, Juan Pablo de Rivero Vaccari, Handong Wang, Paulo Diaz, Ramon German, Alex E Marcillo, Robert W Keane

Open access · greenAbstract read
In one paragraph

Article in Journal of neurotrauma, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 92 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. 2,3,5,4'-Tetrahydroxystilbene-2-Frontiers in cell and developmental biology · 2022
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Xiaoliang WangDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, People's Republic of China.
Juan Pablo de Rivero Vaccari
Handong Wang
Paulo Diaz
Ramon German
Alex E Marcillo
Robert W Keane
Neurological Surgery · USUniversity of Miami · USNanjing General Hospital of Nanjing Military Command · CNNanjing University · CN

Funding

Inflammasome regulation after spinal cord injuryR01NS059836 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI KEANE, ROBERT W · 2010 to 2012
$902k
NINDS NIH HHS NS059836
6 · The paper itself

Abstract

The activation of oxidative damage, neuroinflammation, and mitochondrial dysfunction has been implicated in secondary pathomechanisms following spinal cord injury (SCI). These pathophysiological processes lead to cell death and are tightly regulated by nuclear factor E2-related factor 2/antioxidant response element (Nrf2/ARE) signaling. Here, we investigated whether activation of Nrf2/ARE is neuroprotective following SCI. Female Fischer rats were subjected to mild thoracic SCI (T8) using the New York University injury device. As early as 30 min after SCI, levels of Nrf2 transcription factor were increased in both nuclear and cytoplasmic fractions of neurons and astrocytes at the lesion site and remained elevated for 3 days. Treatment of injured rats with sulforaphane, an activator of Nrf2/ARE signaling, significantly increased levels of Nrf2 and glutamate-cysteine ligase (GCL), a rate-limiting enzyme for synthesis of glutathione, and decreased levels of inflammatory cytokines, interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) thus leading to a reduction in contusion volume and improvement in coordination. These results show that activation of the Nrf2/ARE pathway following SCI is neuroprotective and that sulforaphane is a viable compound for neurotherapeutic intervention in blocking pathomechanisms following SCI.

Indexed as

AnimalsDisease Models, AnimalFemaleImmunoblottingImmunohistochemistryIsothiocyanatesMotor ActivityNeuroprotective AgentsNF-E2-Related Factor 2RatsRats, Inbred F344Response ElementsSignal TransductionSpinal Cord InjuriesSulfoxidesThiocyanatesIsothiocyanatesNeuroprotective AgentsNF-E2-Related Factor 2sulforaphaneSulfoxidesThiocyanates

Identifiers

PMID21806470
PMCPMC3303102
OpenAlexW2045446571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.